BridgeMD
New treatment option for Congenital and Acquired Neuromotor Disorders
Official title Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device
ClinicalTrials.gov ID: NCT07092436
What this study is testing
- What it's testing
- The present investigation is configured as a multicenter clinical study in a within-group pilot phase. This study aims to investigate primarily the feasibility of use and effectiveness of a treatment for upper limb function in children aged 4 to 18 years with congenital and acquired neuromotor disorders through a new portable robotic system, called PhiCube, designed for bilateral neuromotor rehabilitation of the upper limbs in subjects with neuromotor disorders.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 18
You may be able to join if
- For people with congenital and acquired neuromotor disorders:
- Diagnosis of congenital and acquired neuromotor disorders
- Age between 4 and 18 years at the time of recruitment
- Modified Ashworth Scale (MAS) less than 3
- MACS level I-IV
You likely can't join if
- For people with congenital and acquired neuromotor disorders:
- Severe sensory deficits
- Onset of pathologies that prevent participation
- Worsening of pre-existing comorbidities
- For people with developmental coordination disorder (DCD):
- Severe sensory deficits
See the full eligibility criteria
- For people with congenital and acquired neuromotor disorders:
- Diagnosis of congenital and acquired neuromotor disorders
- Age between 4 and 18 years at the time of recruitment
- Modified Ashworth Scale (MAS) less than 3
- MACS level I-IV
- Sufficient capacity to understand the proposed activities
- Availability to attend the facility
- For people with developmental coordination disorder (DCD):
- Diagnosis of developmental coordination disorder (DCD)
- Age between 4 and 18 years at the time of recruitment
- Sufficient capacity to understand the proposed activities
- Availability to attend the facility
- For people with congenital and acquired neuromotor disorders:
- Severe sensory deficits
- Onset of pathologies that prevent participation
- Worsening of pre-existing comorbidities
- For people with developmental coordination disorder (DCD):
- Severe sensory deficits
- Onset of pathologies that prevent participation
- Worsening of pre-existing comorbidities
The study team makes the final eligibility decision.
Where it's taking place
- Bosisio Parini, LC, Italy
- Calambrone, PI, Italy
- Salerno, SA, Italy
- Genova, Italy
- Milan, Italy
- Pavia, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bosisio Parini, LC, Italy; Calambrone, PI, Italy; Salerno, SA, Italy; Genova, Italy; Milan, Italy; Pavia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.